| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.94B | 12.61B | 11.42B | 16.25B | 18.71B | 16.62B |
| Gross Profit | 1.60B | 1.63B | 1.37B | 1.58B | 2.19B | 1.96B |
| EBITDA | 2.08B | 2.26B | 402.00M | 651.98M | 1.32B | 1.06B |
| Net Income | 1.44B | 1.58B | 548.26M | 569.98M | 974.20M | 790.52M |
Balance Sheet | ||||||
| Total Assets | 15.98B | 15.86B | 17.14B | 15.61B | 16.87B | 16.15B |
| Cash, Cash Equivalents and Short-Term Investments | 7.00B | 7.59B | 6.16B | 5.77B | 4.03B | 4.37B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 2.09B | 2.26B | 2.60B | 2.11B | 2.62B | 2.90B |
| Stockholders Equity | 13.89B | 13.59B | 14.54B | 13.51B | 14.24B | 13.25B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 500.71M | 551.90M | 2.52B | 94.59M | 332.71M |
| Operating Cash Flow | 0.00 | 579.79M | 684.68M | 2.54B | 180.01M | 363.91M |
| Investing Cash Flow | 0.00 | 1.52B | 166.77M | 19.76M | -93.61M | -40.68M |
| Financing Cash Flow | 0.00 | -676.56M | -457.99M | -824.05M | -425.58M | -447.16M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥26.90B | 6.28 | ― | 3.63% | 18.02% | 18.04% | |
75 Outperform | ¥55.20B | 16.36 | ― | 2.92% | 3.03% | 28.27% | |
73 Outperform | ¥63.50B | 18.37 | 6.31% | 4.01% | 6.38% | 22.81% | |
70 Outperform | ¥58.51B | -468.17 | ― | 4.37% | -1.09% | ― | |
66 Neutral | ¥37.81B | 11.77 | ― | 2.37% | -11.70% | -54.82% | |
62 Neutral | ¥25.75B | 9.97 | ― | 4.27% | 5.72% | 28.92% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |